Siegfried | chemanager-online.com - Chemistry and Life Science

Sep. 11, 2019
Topics
Experts Statements: Marianne Späne, Siegfried
The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manufacturing to contract development and manufacturing ...
Jul. 16, 2019
Topics
Trend Barometer of Specialty Chemicals Industry
The 34th and, so far, biggest edition of Chemspec Europe attracted a total of 4,295 trade visitors from 53 countries to the exhibition grounds of Messe Basel, Switzerland. During the trade fair, a total of 379 exhibitors from 27 countries ...
Nov. 30, 2018
Topics
Opportunities for Western CDMOs in China
As part of its journey toward being a full-fledged advanced economy, the role and presence of China within the pharmaceutical industry has rapidly evolved throughout the recent years driven by targeted and developing policies. Over the ...
Oct. 03, 2018
Topics
M&A in Pharma and CRO/CMO Industry
Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself. The recent acquisitions of Capsugel by Lonza and of ...
Sep. 21, 2018
Topics
A Wide Spectrum of Contract Services
With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service models that provide both active pharmaceutical ingredient ...
Jun. 04, 2018
News & Opinions
Wolfgang Wienand to Succeed Rudolf Hanko as CEO of Siegfried
Wolfgang Wienand has been appointed as new CEO of Siegfried with effect from Jan. 1, 2019. Rudolf Hanko, the group’s current CEO, will step down on Dec. 31, 2018. The board has decided to propose the election of Hanko as a member of ...
Sep. 13, 2016
Topics
The Winning Formula
Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs. Indeed, medicinal chemists face a challenge of their own. ...
Sep. 12, 2016
Topics
Experts Statements: Dr. René Imwinkelried, Siegfried
Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs. Indeed, medicinal chemists face a challenge of their own. ...
Sep. 12, 2016
Topics
The Winning Formula
Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs. Indeed, medicinal chemists face a challenge of their own. ...
Jun. 09, 2016
Topics
Addressing The Pharma Innovation Gap
Since the beginning of the 21st century, pharma M&A activity has exploded. Mergers and acquisitions, layoffs, and outsourcing of research and manufacturing have become common place in an industry that had previously been nearly immune ...

12 3

Register now!

The latest information directly via newsletter.

GIT Verlag